Man Group
LXRX icon

Man Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Man Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170K Buy
+108,806
New +$158K ﹤0.01% 2317
2019
Q1 		– Sell
-20,500
Closed -$136K – 2022
2018
Q4 		$136K Buy
+20,500
New +$166K ﹤0.01% 1835

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Man Group's LXRX Position: Q1 2026 in Review

Man Group opened a new position in Lexicon Pharmaceuticals (LXRX) in Q1 2026: 108,806 shares worth $170K. The stake represents ﹤0.01% of the portfolio and ranks #2317 among its holdings. This is a return to the name: Man Group previously reported a position in LXRX as recently as Q4 2018.

Man Group first reported a position in LXRX in Q4 2018 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Man Group held 108,806 shares of Lexicon Pharmaceuticals worth $170K as of Q1 2026.
  • Lexicon Pharmaceuticals was a new Man Group position in Q1 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2317 holding.
  • Man Group first reported a position in Lexicon Pharmaceuticals in Q4 2018 and has held it in 2 quarters since.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.